Qiubing Chen
Impact in
- Pharmaceutical Science top 2%
- Molecular Medicine top 5%
Papers in
-
- RNA Interference and Gene Delivery 8
- CRISPR and Genetic Engineering 6
- Advanced biosensing and bioanalysis techniques 4
-
- Nanoplatforms for cancer theranostics 6
- Co-authors
- Bo Xiao (17 shared papers)Hao Yin (9 shared papers)Yuejun Kang (11 shared papers)Liang Zeng (3 shared papers)Menghang Zu (3 shared papers)Liyong Luo (2 shared papers)Xinlin Lei (5 shared papers)Didier Merlin (5 shared papers)
- Journals
- Acta Pharmaceutica Sinica B (2 papers)Colloids and Surfaces B Biointerfaces (2 papers)Nature Biomedical Engineering (2 papers)Journal of Nanobiotechnology (2 papers)ACS Applied Materials & Interfaces (2 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Qiubing Chen
39 papers receiving 2.1k citations
Qiubing Chen's Hit Papers
Peers
Comparison fields: 5 of 119
- Pharmaceutical Science 160
- Molecular Medicine 111
- Biomaterials 284
- Molecular Biology 1.2k
- Cancer Research 184
Countries citing papers authored by Qiubing Chen
This map shows the geographic impact of Qiubing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiubing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiubing Chen more than expected).
Fields of papers citing papers by Qiubing Chen
This network shows the impact of papers produced by Qiubing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiubing Chen. The network helps show where Qiubing Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Qiubing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Fast and sensitive detection of SARS-CoV-2 RNA using suboptimal protospacer adjacent motifs for Cas12a Hit paper breakdown → | 2022 | 291 |
| 2 | Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation Hit paper breakdown → | 2021 | 257 |
| 3 | Tea leaf-derived exosome-like nanotherapeutics retard breast tumor growth by pro-apoptosis and microbiota modulation Hit paper breakdown → | 2023 | 144 |
| 4 | 2018 | 116 | |
| 5 | 2020 | 115 | |
| 6 | 2020 | 99 | |
| 7 | 2018 | 97 | |
| 8 | 2018 | 90 | |
| 9 | 2020 | 75 | |
| 10 | 2021 | 73 | |
| 11 | 2020 | 72 | |
| 12 | 2018 | 61 | |
| 13 | 2018 | 48 | |
| 14 | 2023 | 46 | |
| 15 | 2020 | 37 | |
| 16 | 2021 | 36 | |
| 17 | 2017 | 34 | |
| 18 | 2016 | 33 | |
| 19 | 2018 | 33 | |
| 20 | 2017 | 32 |
About Qiubing Chen
Qiubing Chen is a scholar working on Molecular Biology, Biomedical Engineering, Pathology and Forensic Medicine, Biomaterials and Molecular Medicine, having authored 40 papers that have together received 2.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (8 papers), CRISPR and Genetic Engineering (6 papers), Nanoplatforms for cancer theranostics (6 papers), Inflammatory Bowel Disease (5 papers), Nanoparticle-Based Drug Delivery (5 papers), Curcumin's Biomedical Applications (5 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Advanced Drug Delivery Systems (4 papers). The work is most often cited by research in Pharmaceutical Science (160 citations), Molecular Medicine (111 citations), Biomaterials (284 citations), Molecular Biology (1.2k citations) and Cancer Research (184 citations). Qiubing Chen has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Bo Xiao, Hao Yin, Yuejun Kang, Liang Zeng, Menghang Zu, Liyong Luo, Xinlin Lei, Didier Merlin, Ying Zhang and Zhigang Xu. Their work appears in journals such as Acta Pharmaceutica Sinica B, Colloids and Surfaces B Biointerfaces, Nature Biomedical Engineering, Journal of Nanobiotechnology and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.